Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
creator: Solomon Habtemariam, Ioana Berindan-Neagoe, Maciej Banach, Mahdi Bagheri, Morteza Izadi, Emilio Clementi, Mahsa Rasekhian, Mohammad Bagheri, Seyed Nabavi, Cosmin Cismaru
source: Archives of Medical Science
publisher: Termedia Publishing House
date: 2020
identifier: DOI: 10.5114/aoms.2020.94504
coverage: Medicine